Research Topic · Peer-Reviewed

Refractory Disease

Refractory disease is a medical condition that is resistant to standard treatments and therapies. It is often a result of a mutation or abnormality in the patient’s DNA, causing the disease to become unresponsive to traditional treatments. Refractory Diseases may include cancers, genetic Diseases, cardiovascular Dis…

Curated from this journal's research 📚 4 peer-reviewed articles cited Cited 4× across the literature 🔖 ISSN 2997-1977 🗓 Reviewed July 2026

Overview

Refractory disease is a medical condition that is resistant to standard treatments and therapies. It is often a result of a mutation or abnormality in the patient’s DNA, causing the disease to become unresponsive to traditional treatments. Refractory Diseases may include cancers, genetic Diseases, cardiovascular Diseases, and autoimmune Diseases, among many others. The management of refractory Diseases typically involve a combination of medications and therapies, with a goal of improving a patient’s quality of life. As such, the treatment of refractory Diseases presents unique challenges to healthcare professionals, as it requires personalized care. Refractory disease management is essential for improving the health and well-being of patients, as it strives to provide maximum relief from the symptoms of the disease.

Research published in this journal

4 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 4 articles above have been cited 4 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Refractory Disease, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Diseases (ISSN 2997-1977).

Journal editorial board
Madalena Barroso · Germany VASSILIKI PITIRIGA · Greece Andrzej Prystupa · Poland

This page summarises published research for orientation; it is not medical or professional advice.